Genic Co., Ltd. (KOSDAQ:123330)

Market Cap	242.96B +20.3%
Revenue (ttm)	78.20B +56.7%
Net Income	18.89B +149.7%
EPS	2,414.00 +133.0%
Shares Out	7.82M
PE Ratio	12.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	275,242
Average Volume	378,680
Open	31,650
Previous Close	31,250
Day's Range	30,700 - 34,300
52-Week Range	15,570 - 44,100
Beta	1.55
RSI	63.54
Earnings Date	Apr 2, 2026

About Genic

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2001
• Employees: 324
• Stock Exchange: KOSDAQ
• Ticker Symbol: 123330

Financial Performance

In 2025, Genic's revenue was 78.20 billion, an increase of 56.68% compared to the previous year's 49.91 billion. Earnings were 18.89 billion, an increase of 149.73%.